Showing results (31-40 of 183) with videos related to

Sort By:
Pageof 19
BMJ Open|June 1, 2023
ALL-RIC trial protocol: a comparison of reduced dose total body irradiation (TBI) and cyclophosphamide with fludarabine and melphalan reduced intensity conditioning in adults with acute lymphoblastic leukaemia (ALL) in complete remissionDavid I Marks, Anna Castleton, Eduardo Olavarria, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2019
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host DiseasePartow Kebriaei, Jack Hayes, Andrew Daly, et al.
Blood|October 22, 2005
Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation StudyJulio Delgado, Kirsty Thomson, Nigel Russell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2010
Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for relapsed and refractory mantle cell lymphoma (MCL): a study of the British Society for Blood and Marrow TransplantationGordon Cook, Graeme M Smith, Keiren Kirkland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2011
Factors influencing the outcome of a second autologous stem cell transplant (ASCT) in relapsed multiple myeloma: a study from the British Society of Blood and Marrow Transplantation RegistryGordon Cook, Effie Liakopoulou, Rachel Pearce, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry studyAndrew D Chantry, John A Snowden, Charles Craddock, et al.
British Journal of Haematology|July 19, 2006
Haploidentical stem cell transplantation for children with acute leukaemiaDavid I Marks, Navin Khattry, Michelle Cummins, et al.
Transplantation and Cellular Therapy|July 22, 2023
Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell TransplantationMuhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, et al.
British Journal of Haematology|September 2, 2011
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantationDavid I Marks, Antonio Pagliuca, Christopher C Kibbler, et al.
British Journal of Haematology|November 25, 2003
The outcome of unrelated donor stem cell transplantation for patients with multiple myelomaBronwen E Shaw, Karl Peggs, Jennifer M Bird, et al.
Pageof 19